Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.
Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).
Article: " Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease," by Long Teng, Fang Hong, Chenguang Zhang, Jiancheng He, Haiying Wang (Shanghai University of Traditional Chinese Medicine, Shanghai, China)
Novel antibiotic compound shows promise against drug-resistant bacteria and flesh-eating infections